Cancer: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 65: | Line 65: | ||
<br /> | <br /> | ||
====FDA Approved Treatments for [[Cancer]]==== | |||
<table style="background: cellspacing="5px" cellpadding="10px" width="100%"> | |||
<tr> | |||
<td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> | |||
=====[[EGFR]] Inhibitor===== | |||
* Herceptin - Generic: Trastuzumab | |||
* [[Iressa]] - Generic: Gefitinib | |||
* [[Tarceva]] - Generic: Erlotinib | |||
=====[[VEGF]] Inhibitor===== | |||
* Avastin - Generic: Bevacizumab | |||
* Tykerb - Generic: Lapatinib | |||
* Sutent - Generic: Sunitinib | |||
* Nexavar - Generic: Sorafenib | |||
</td> | |||
</tr> | |||
</table> | |||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | ||
